Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
New chemotherapy protocol for canine lymphoma
Different protocols exist to treat lymphomas in dogs, almost all of them base on a remission protocol followed by a maintenance protocol. This study compares a maintenance-free chemotherapy protocol based on CHOP (H from hydroxydaunorubicin = doxorubicin, O from Oncovin = vincristine) to a similar protocol with a maintenance phase for the treatment of canine lymphoma.

Fifty-three dogs with multicentric lymphoma were treated with a 6-month modified version of the University of Wisconsin (UW)-Madison chemotherapy protocol (UW-25). Disease-free interval (DFI) and survival were compared to a historical control group of 55 dogs treated with a similar protocol with a prolonged maintenance phase. Remission rate for the study dogs was 94.2% (complete remission = 92.3%, partial remission = 1.9%). DFI and survival between the 2 groups did not differ significantly, with median DFI and survival of the study dogs equal to 282 and 397 days compared to 220 and 303 days for the control dogs (P = .2835 and .3365, respectively). Univariate analysis identified substage b (P = .0087), German Shepherd breed (P = .0199), and body weight > 18 kg (P = .0016) as significant for worse survival. Longer survival was associated with thrombocytopenia (P = .0436). Multivariate analysis revealed that substage (P = .0388) and weight (P = .0125) retained significance for DFI, whereas substage (P = .0093), thrombocytopenia (P = .0150), and weight (P = 0 .0050) retained significance for survival. Overall, the protocol was well tolerated by the dogs, with 41.5% (22/53) requiring a treatment delay or dose modification, but only 9.4% (5/53) needing hospitalization. The 6-month chemotherapy protocol based on CHOP with no maintenance phase provides similar DFI and survival times when compared to a similar protocol with a prolonged maintenance phase.


Source: Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM (2002): Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. In: J Vet Intern Med 2002 Nov-Dec;16(6):704-9






Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

In-hospital ECG versus 24-hour Holter in dogs with atrial fibrillationmembers
Atrial fibrillation is a potentially life-threatening condition which requires good management including good monitoring. The objective of this study was to determine if the in-clinic ECG-derived heart rate could predict the at-home Holter-derived 24-hour average heart rate (Holter24h), and whether it is useful to identify slow versus fast atrial fibrillation in dogs.

  • Novel radiation therapy for inoperable massive hepatocellular carcinoma members
  • Red blood cell storage lesion - an updatemembers
  • Coagulation abnormalities in dogs following severe acute traumamembers
  • Ultrasound-guided epidural access at the lumbo-sacral spacemembers
  • Thrombelastometry in dogs undergoing orthopedic surgerymembers
  • COX-2 inhibitors after phacoemulsification cataract removalmembers
  • First report of achromatopsia in related Labrador Retriever without CNGB3 mutations members
  • Acute kidney injury in severe sepsismembers
  • First description of orbital pneumatosis in a young catmembers
  • Serum antibodies to βA1-crystallin and cataract formation in Cocker spanielsmembers
  • Canine osteosarcoma cells and aurora kinase inhibitorsmembers
  • Long-term compassionate use of oclacitinib in dogs with allergic skin diseasemembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2013 VetContact GmbH
    All rights reserved